Navigation Links
Herpes medication does not reduce risk of HIV transmission
Date:5/8/2009

A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.

The majority of people with HIV infection also have HSV-2 infection. Multiple studies have shown that frequent genital herpes recurrences increase the amount of HIV in the blood and genital tract. The HIV virus is also shed from genital herpes ulcers and individuals with such ulcers transmit HIV to others more efficiently. Five preliminary studies showed that it is possible to decrease the amount of HIV in the blood and genital tract through treatment to suppress HSV-2, but these studies did not measure whether this translated into a reduction in HIV transmission. Researchers had hoped that acyclovir's ability to suppress the herpes virus, which causes symptomatic genital sores and breaks in the skin but also frequently is active without symptoms, could reduce the likelihood of sexual transmission of HIV from a person with HIV and HSV-2. The study being reported today is the first to determine whether twice daily use of acyclovir by individuals who are infected with both HSV-2 and HIV reduced the transmission of HIV to their sexual partners.

Led by the University of Washington in Seattle and funded by the Bill & Melinda Gates Foundation, the Partners in Prevention HSV/HIV Transmission Study was conducted among 3,408 African HIV discordant couples, in which one partner had HIV and the other did not. In all the couples, the partner who had HIV also had HSV-2 infection. The study took place at 14 sites in seven countries in eastern and southern Africa (Botswana, Kenya, Rwanda, South Africa, Tanzania, Uganda and Zambia). In sub-Saharan Africa, the majority of new HIV infections occur among heterosexual HIV discord
'/>"/>

Contact: Mary Guiden
mguiden@u.washington.edu
206-616-3192
University of Washington
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Treatment Target for Herpes Pinpointed
2. Herpes: Scientists find cellular process that fights virus
3. In Time, Cream Might Prevent Herpes Transmission
4. Herpes drug inhibits HIV replication, but with a price
5. Herpes Suppression May Not Prevent HIV Infection
6. Study Ties Herpes Virus to Emerging Form of Diabetes
7. Study finds genetic link to human herpes susceptibility
8. Study shows suppressing herpes virus may reduce infectiousness of HIV
9. Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)
10. Seniors Should Watch for Drug Interactions When Taking Multiple Medications
11. Electronic Prior Authorization Program to Help Patients Get Faster Access to Prescription Medication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Healthpointe Medical Group, one of ... center from LAXMed. The medical center is less than 2 ... west of the 405 freeway. , The LAX clinic ... LAX center is located at: 8610 S. Sepulveda Blvd., Suite ... Healthpointe LAX office will provide the same comprehensive services ...
(Date:8/29/2014)... The family of a California woman ... dialysis treatments has filed a GranuFlo lawsuit ( http://www.thegranuflolawsuit.com ... of Fresenius Medical Care’s GranuFlo and NaturaLyte dialysis concentrates, ... file d in Alameda County Superior Court on July ... resulted in metabolic alkalosis, a dangerous elevation of ...
(Date:8/29/2014)... 29, 2014 Today, NBC’s “The ... who profiled a handful of safe, back to ... Research. This year, many schools will include earphones ... innovator of hearing wellness solutions, offers the best ... Earphones, offered in yellow, pink and black, sound ...
(Date:8/29/2014)... Reinberg HealthDay Reporter ... majority of American babies are getting the vaccines they ... officials said Thursday. More than 90 percent of ... and rubella (MMR); polio; hepatitis B and chickenpox (varicella), ... Prevention. "Nationally, vaccination among children 19 to 35 ...
(Date:8/29/2014)... Food and Drug Administration (FDA)-approved treatment for decreasing ... effective at reducing fracture risk as other current ... loss. With the use of wide- and small-angle ... out experiments at the U.S. Department of Energy,s ... Laboratory that revealed an additional mechanism underlying raloxifene ...
Breaking Medicine News(10 mins):Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Revealing a novel mode of action for an osteoporosis drug 2
... with a drug that targets two genes that ... this deadly disease, according to cancer researchers. The ... safer and more effective way of targeting cancer-causing ... , "It is a very selective and ...
... message boards, videos and advice , , MONDAY, Sept. 15 ... cancer patients learn more about how they can preserve ... Northwestern University in Chicago. , "It,s overwhelming for ... fertility preservation at the same time that they are ...
... Sept. 15 Yearbook photos capture school,portraits for years ... a,yearbook photo that they would prefer to erase -- ... yearbook photos this year, and to,kick-off the launch of ... & CLEAR(R) is inviting teens to,"Erase Their Worst Year ...
... Consumer coalition calls for quality standards to protect Pennsylvania ... families from inadequate regulations, ... allow facilities to rent rooms to residents that,do not meet ... wheelchairs or walkers., While new assisted living construction would ...
... LSU Health Sciences Center New Orleans School of ... the Robert Wood Johnson Foundation (RWJF) to provide ... disadvantaged backgrounds in an accelerated nursing degree program. ... Career Alternative RN Education, or CARE, Program, expanding ...
... HILL Nearly every child who receives an antipsychotic ... atypical drugs, such as olanzapine and risperidone. However, there ... effective than the older, first-generation medications., ,Now a study ... School of Medicine suggests that molindone, a first-generation drug, ...
Cached Medicine News:Health News:Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively 2Health News:Nanomedical approach targets multiple cancer genes, shrinks tumors more effectively 3Health News:Web Site Helps Cancer Patients With Fertility Preservation 2Health News:CLEAN & CLEAR(R) Is Inviting Teens to 'Erase Their Worst Yearbook Picture' With The NEW CLEAN & CLEAR(R) Advantage(R) Blackhead Eraser(TM) Exfoliating Cleanser 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 2Health News:Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers 3Health News:LSUHSC awarded grant to address nursing shortage 2Health News:First generation antipsychotic drugs as effective as newer ones in some children 2Health News:First generation antipsychotic drugs as effective as newer ones in some children 3
(Date:8/29/2014)... , Aug. 29, 2014 The clinical and ... be the difference between a product,s success or failure. ... and stratify KOL targets – and then to coordinate ... of strong relationships upon which successful KOL engagement rests. ... companies have identified internal inconsistencies in their KOL management ...
(Date:8/29/2014)... The Competitive Intelligence (CI) function is evolving ... leaders who adjust will succeed, and those who don,t ... Practices, LLC study CI leaders from 32 biopharmaceutical organizations ... - Use secondary research whenever possible - it,s effective, ... Internal staff who are creative thinkers provide the CI ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
Breaking Medicine Technology:Implementing a Strategic Thought Leader Management & Engagement System 2Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2
... The Integrity ADx pacemaker ... world's smallest dual-chamber pacemaker, ... pacemaker technology, including the ... the first U.S. commercially ...
... The Affinity pacemaker ... today's smallest, truly automatic ... effective combination of advanced ... Affinity DR pacemaker incorporates ...
Innovative new tools for more efficient patient management begin when the pacemaker is implanted. These sophisticated tools are in effect each day, and they help automate follow-up tasks....
... The first-ever completely automatic ... that make it sophisticated yet ... a wide range of diagnostic ... without clinician intervention. This allows ...
Medicine Products: